223 related articles for article (PubMed ID: 22453175)
1. Misfolded PrP and a novel mechanism of proteasome inhibition.
Andre R; Tabrizi SJ
Prion; 2012; 6(1):32-6. PubMed ID: 22453175
[TBL] [Abstract][Full Text] [Related]
2. Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration.
Lin Z; Zhao D; Yang L
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):477-84. PubMed ID: 23449072
[TBL] [Abstract][Full Text] [Related]
3. Prions and the proteasome.
Deriziotis P; Tabrizi SJ
Biochim Biophys Acta; 2008 Dec; 1782(12):713-22. PubMed ID: 18644436
[TBL] [Abstract][Full Text] [Related]
4. Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system.
McKinnon C; Goold R; Andre R; Devoy A; Ortega Z; Moonga J; Linehan JM; Brandner S; Lucas JJ; Collinge J; Tabrizi SJ
Acta Neuropathol; 2016 Mar; 131(3):411-25. PubMed ID: 26646779
[TBL] [Abstract][Full Text] [Related]
5. Prion-Associated Neurodegeneration Causes Both Endoplasmic Reticulum Stress and Proteasome Impairment in a Murine Model of Spontaneous Disease.
Otero A; Betancor M; Eraña H; Fernández Borges N; Lucas JJ; Badiola JJ; Castilla J; Bolea R
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466523
[TBL] [Abstract][Full Text] [Related]
6. Selective processing and metabolism of disease-causing mutant prion proteins.
Ashok A; Hegde RS
PLoS Pathog; 2009 Jun; 5(6):e1000479. PubMed ID: 19543376
[TBL] [Abstract][Full Text] [Related]
7. Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry.
Deriziotis P; André R; Smith DM; Goold R; Kinghorn KJ; Kristiansen M; Nathan JA; Rosenzweig R; Krutauz D; Glickman MH; Collinge J; Goldberg AL; Tabrizi SJ
EMBO J; 2011 Jul; 30(15):3065-77. PubMed ID: 21743439
[TBL] [Abstract][Full Text] [Related]
8. Disease-associated prion protein oligomers inhibit the 26S proteasome.
Kristiansen M; Deriziotis P; Dimcheff DE; Jackson GS; Ovaa H; Naumann H; Clarke AR; van Leeuwen FW; Menéndez-Benito V; Dantuma NP; Portis JL; Collinge J; Tabrizi SJ
Mol Cell; 2007 Apr; 26(2):175-88. PubMed ID: 17466621
[TBL] [Abstract][Full Text] [Related]
9. Conformational conversion of prion protein in prion diseases.
Zhou Z; Xiao G
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):465-76. PubMed ID: 23580591
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin-A-induced prion protein aggresomes are dynamic quality-control cellular compartments.
Ben-Gedalya T; Lyakhovetsky R; Yedidia Y; Bejerano-Sagie M; Kogan NM; Karpuj MV; Kaganovich D; Cohen E
J Cell Sci; 2011 Jun; 124(Pt 11):1891-902. PubMed ID: 21558416
[TBL] [Abstract][Full Text] [Related]
11. The relationship between the 20S proteasomes and prion-mediated neurodegenerations: potential therapeutic opportunities.
Cecarini V; Bonfili L; Cuccioloni M; Mozzicafreddo M; Angeletti M; Eleuteri AM
Apoptosis; 2010 Nov; 15(11):1322-35. PubMed ID: 20213200
[TBL] [Abstract][Full Text] [Related]
12. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.
Ma J; Wollmann R; Lindquist S
Science; 2002 Nov; 298(5599):1781-5. PubMed ID: 12386337
[TBL] [Abstract][Full Text] [Related]
13. The Prion Concept and Synthetic Prions.
Legname G; Moda F
Prog Mol Biol Transl Sci; 2017; 150():147-156. PubMed ID: 28838659
[TBL] [Abstract][Full Text] [Related]
14. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
15. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders.
Mishra RS; Bose S; Gu Y; Li R; Singh N
J Alzheimers Dis; 2003 Feb; 5(1):15-23. PubMed ID: 12590162
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of neurotoxicity of pathological prion protein.
Castilla J; Hetz C; Soto C
Curr Mol Med; 2004 Jun; 4(4):397-403. PubMed ID: 15354870
[TBL] [Abstract][Full Text] [Related]
17. The Unexposed Secrets of Prion Protein Oligomers.
Wang G; Wang M; Li C
J Mol Neurosci; 2015 Aug; 56(4):932-937. PubMed ID: 25823438
[TBL] [Abstract][Full Text] [Related]
18. Prion protein and its conformational conversion: a structural perspective.
Surewicz WK; Apostol MI
Top Curr Chem; 2011; 305():135-67. PubMed ID: 21630136
[TBL] [Abstract][Full Text] [Related]
19. Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations.
Fioriti L; Dossena S; Stewart LR; Stewart RS; Harris DA; Forloni G; Chiesa R
J Biol Chem; 2005 Mar; 280(12):11320-8. PubMed ID: 15632159
[TBL] [Abstract][Full Text] [Related]
20. Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70).
Mays CE; Armijo E; Morales R; Kramm C; Flores A; Tiwari A; Bian J; Telling GC; Pandita TK; Hunt CR; Soto C
J Biol Chem; 2019 Sep; 294(37):13619-13628. PubMed ID: 31320473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
